WO2009139655A3 - The use of an exopolysaccharide fraction produced by Lactobacillus rhamnosus - Google Patents
The use of an exopolysaccharide fraction produced by Lactobacillus rhamnosus Download PDFInfo
- Publication number
- WO2009139655A3 WO2009139655A3 PCT/PL2009/050008 PL2009050008W WO2009139655A3 WO 2009139655 A3 WO2009139655 A3 WO 2009139655A3 PL 2009050008 W PL2009050008 W PL 2009050008W WO 2009139655 A3 WO2009139655 A3 WO 2009139655A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lactobacillus rhamnosus
- fraction produced
- exopolysaccharide
- exopolysaccharide fraction
- kl37c
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Abstract
A use is revealed for a fraction containing an exopolysaccharide isolated from bacteria of the species Lactobacillus rhamnosus, preferentially, the Lactobacillus rhamnosus strain KL37C deposited in the PCM under the accession number B/00022, in the production of a drug for the prophylaxis and treatment of autoimmune diseases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL385187A PL385187A1 (en) | 2008-05-14 | 2008-05-14 | Application of exopolysaccharides fraction obtained from Lactobacillus rhamnosus |
PLPL385187 | 2008-05-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009139655A2 WO2009139655A2 (en) | 2009-11-19 |
WO2009139655A3 true WO2009139655A3 (en) | 2010-04-15 |
Family
ID=41210651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/PL2009/050008 WO2009139655A2 (en) | 2008-05-14 | 2009-05-14 | The use of an exopolysaccharide fraction produced by Lactobacillus rhamnosus |
Country Status (2)
Country | Link |
---|---|
PL (1) | PL385187A1 (en) |
WO (1) | WO2009139655A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101112648B1 (en) | 2008-12-30 | 2012-02-16 | 고려대학교 산학협력단 | Method of producing exopolysaccharide |
US10383888B2 (en) * | 2015-04-10 | 2019-08-20 | University Of Massachusetts | Exopolysaccharide for inflammatory disease |
CN114717130B (en) * | 2021-09-07 | 2023-08-29 | 青岛蔚蓝生物股份有限公司 | Lactobacillus rhamnosus capable of producing exopolysaccharide at high yield and application of lactobacillus rhamnosus in relieving skin injury |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007108763A1 (en) * | 2006-03-17 | 2007-09-27 | Probac Ab | Use of lactobacillus strains for promoting immunotolerance in autoimmune disease |
-
2008
- 2008-05-14 PL PL385187A patent/PL385187A1/en not_active Application Discontinuation
-
2009
- 2009-05-14 WO PCT/PL2009/050008 patent/WO2009139655A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007108763A1 (en) * | 2006-03-17 | 2007-09-27 | Probac Ab | Use of lactobacillus strains for promoting immunotolerance in autoimmune disease |
Non-Patent Citations (1)
Title |
---|
LIPINSKI T ET AL: "Structural analysis of the Lactobacillus rhamnosus strain KL37C exopolysaccharide", CARBOHYDRATE RESEARCH, PERGAMON, GB, vol. 338, no. 7, 28 March 2003 (2003-03-28), pages 605 - 609, XP004414775, ISSN: 0008-6215 * |
Also Published As
Publication number | Publication date |
---|---|
PL385187A1 (en) | 2009-11-23 |
WO2009139655A2 (en) | 2009-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011026906A3 (en) | Novel microorganism and its use in lignocellulose detoxification | |
RU2010146956A (en) | NEW LACTOBACILLUS PARACASEI SUBSPECIES PARACASEI STRAIN WITH ANTIMICROBIAL AND IMMUNOMODULATING PROPERTIES | |
NZ597774A (en) | Bacterial expression of an artificial gene for the production of cross reactive material 197 and its derivatives | |
WO2009068214A3 (en) | Heteroaryl-substituted piperidines | |
UA93542C2 (en) | Strain of lactic acid bacterium streptococcus thermophilus providing for improved structure of fermented products | |
WO2010055499A3 (en) | Bifidobacterium longum | |
WO2008104306A3 (en) | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | |
NZ703725A (en) | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof | |
NZ602201A (en) | A novel ethanologenic clostridium species, clostridium coskatii | |
WO2009142472A3 (en) | Bifidobacteria that produces folic acid, food composition and use of said bifidobacteria | |
RU2010142489A (en) | STRAIN LACTOBACILLUS RHAMNOSUS | |
WO2007025977A8 (en) | Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis | |
WO2008155069A3 (en) | Substituted oxazolidinones and use thereof | |
UA101316C2 (en) | Normal;heading 1;heading 2;heading 3;USE OF SELECTED LACTIC ACID BACTERIA FOR REDUCING ATHEROSCLEROSIS | |
NZ600292A (en) | Anti-microbial agent from paenibacillus sp. and methods and uses thereof | |
RS54837B1 (en) | Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract | |
WO2013041969A3 (en) | Didemnin biosynthetic gene cluster in tistrella mobilis | |
WO2006071746A3 (en) | Engineered dopamine neurons and uses thereof | |
WO2009139655A3 (en) | The use of an exopolysaccharide fraction produced by Lactobacillus rhamnosus | |
DK1787651T3 (en) | Bacterial culture that inhibits the development of dermatitis and accelerates the healing of skin ulcers as well as product that uses the same | |
WO2009098411A3 (en) | Use of l. casei ssp. paracasei as antifungal agent | |
SG11202000113QA (en) | Composition comprising lactobacillus plantarum cjlp475 strain and lactobacillus plantarum cjlp243 strain and use thereof | |
WO2008120486A1 (en) | Novel microorganism | |
MX2014001572A (en) | New strain of l. bulgaricus capable of inhibiting the adhesion of h. pylori strains to epithelial cells. | |
WO2009059054A3 (en) | Bacteria strains an d bacteriocin produced therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09746830 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09746830 Country of ref document: EP Kind code of ref document: A2 |